Accessibility Menu
Extendicare logo

Extendicare(OTC) EXETF

Market Cap$2.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+744%
5 Year+361%
1 Year+155%
1 Month-10%
$23.26
+0.70%
+0.16Today
Extendicare last closing stock price
MetricPriceDate
Last closeUSD 23.102026-08-07
Extendicare stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.63%USD 25.282026-07-31
1 month-10.43%USD 25.792026-07-08
3 month-5.17%USD 24.362026-05-08
Year to date+50.25%USD 15.372025-12-31
1 year+154.71%USD 9.072025-08-07
3 year+397.49%USD 4.642023-08-08
5 year+360.91%USD 5.012021-08-06
Since inception+744.28%USD 2.742011-10-12

Extendicare Financials at a Glance

Market Cap

$2.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$1.75B

Net Income (TTM)

CA$122.44M

EPS (TTM)

$0.99

P/E Ratio

23.11

Dividend

$0.37

Beta (Volatility)

0.24 (Low)

Price

$23.26

Volume

236,846

Open

$23.10

Previous Close

$23.26

Daily Range

$22.70 - $23.26

52-Week Range

$9.34 - $28.45

Estimated Earnings Date

Aug 6, 2026

EXETF News

I’m Buying More Extendicare

Jim RoyalSep 5, 2014

I'm Buying More Extendicare

Jim RoyalDec 11, 2013

I'm Buying Extendicare

Jim RoyalDec 9, 2013

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Extendicare

Extendicare Inc. is a prominent Canadian provider specializing in a comprehensive range of care and support services for seniors. The company operates residential long-term care facilities, retirement living options, and in-home health support services, making it a key player in the healthcare sector.

Products and Services
  • Residential long-term care facilities for seniors
  • In-home health support including nursing and therapy services
  • Consulting and contract services for healthcare organizations
Growth Outlook
  • Strong demand for senior care services due to an aging population
  • Expansion of home health care services to meet increasing needs
  • Strategic investments in technology to enhance service delivery
Financial Highlights
  • Recent quarterly revenue of CAD 466.4 million, showing consistent growth
  • Trailing twelve months (TTM) net income of CAD 40.8 million, reflecting operational efficiency
  • Dividend yield of 1.41%, indicating a commitment to returning value to shareholders
Extendicare Inc. has established itself as a leader in the healthcare industry, particularly in the senior care segment. With a robust portfolio of services, the company is well-positioned to capitalize on the growing demand for senior care solutions. The aging population in Canada presents a significant opportunity for growth, and Extendicare's strategic focus on expanding its home health care services aligns with this trend. Recent financial performance indicates a solid revenue stream and profitability, underscoring the company's operational effectiveness. The commitment to shareholder returns through dividends further enhances its appeal to potential investors. Overall, Extendicare Inc. represents a compelling opportunity within the healthcare sector, driven by demographic trends and a strong service offering.
AI Generated • Jul 31, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

22,000

CEO

Michael R. Guerriere, PhD, MBA

Website

www.extendicare.com

Headquarters

Markham, ON L3R 4T9, CA

EXETF Financials

Key Financial Metrics (TTM)

Gross Margin

31.62%

Operating Margin

8.79%

Net Income Margin

6.99%

Return on Equity

45.35%

Return on Capital

19.32%

Return on Assets

11.42%

Earnings Yield

4.33%

Dividend Yield

1.61%

Payout Ratio

35.62%

Stock Overview

Market Cap

$2.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

95.05M

Volume

236.85K

Avg. Volume

122.19K

Financials (TTM)

Gross Profit

CA$938.08M

Operating Income

CA$154.04M

EBITDA

CA$206.07M

Operating Cash Flow

CA$143.13M

Capital Expenditure

-CA$93.89M

Free Cash Flow

CA$49.24M

Cash & ST Invst.

CA$323.10M

Total Debt

CA$325.40M

Extendicare Performance Analysis

Extendicare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 938,336,7720.8%
20232023-12-31CAD 966,859,0083.0%
20242024-12-31CAD 1,070,250,44910.7%
20252025-12-31CAD 1,188,307,15511.0%
Extendicare sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-302.3%
Q32025-09-3014.8%
Q42025-12-314.9%
Q12026-03-311.0%
Extendicare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.04N/A
20232023-12-31CAD 0.30N/A
20242024-12-31CAD 0.5894.3%
20252025-12-31CAD 0.8038.4%
Extendicare sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30105.6%
Q32025-09-30-24.3%
Q42025-12-313.6%
Q12026-03-3144.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$466.43M

+24.5%

Gross Profit

CA$59.02M

-84.2%

Gross Margin

12.65%

N/A

Market Cap

$2.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$93.42K

N/A

Employees

23,500

N/A

Net Income

CA$40.84M

+171.7%

EBITDA

CA$52.99M

+65.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$323.10M

+195.1%

Total Debt

CA$325.40M

+13.4%

Accounts Receivable

CA$106.68M

+17.0%

Inventory

CA$0.00

N/A

Long Term Debt

CA$305.81M

+13.1%

Short Term Debt

CA$19.59M

+18.6%

Return on Assets

11.42%

N/A

Return on Invested Capital

20.49%

N/A

Free Cash Flow

-CA$11.98M

-501.9%

Operating Cash Flow

-CA$4.42M

-124.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LTGHYLife Healthcare Group Holdings Limited
$2.89+1.40%
GNMLFGenomma Lab Internacional, S.A.B. de C.V.
$0.84+0.60%
WHTCFWELL Health Technologies Corp.
$2.95-2.96%
PHCIPanamera Holdings Corporation
$2.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$138.74+0.04%
ACHRArcher Aviation
$6.26+0.12%
NVDANvidia
$217.55-0.03%
INTCIntel
$97.52-0.04%

Questions About EXETF

What is the current price of Extendicare?

Extendicare is trading at $23.26 per share.

What is the 52-week range for Extendicare?

Over the past 52 weeks, Extendicare has traded between $9.34 and $28.45.

How much debt does Extendicare have?

As of the most recent reporting period, Extendicare reported total debt of CA$455.15M.

How much cash does Extendicare have on hand?

Extendicare reported CA$66.70M in cash and cash equivalents in its most recent financial results.

What is Extendicare’s dividend yield?

Extendicare currently has a dividend yield of 1.61%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services